Fromm G, De Silva S, Giffin L, Xu X, Rose J, S chreiber TH. P206 Gp96 -Ig/costimulator (OX40L, ICOSL, or 4 -1BBL) combination vaccine improves T cell priming and enhances immunity, memory, and tumor elimination. Journal for Immunotherapy of Cancer 2016;4:116. 21. Strbo N, Vaccari M, Pahwa S, et al. Novel vaccination modality provides significant protection against mucosal infection by highly pathogenic SIV . Journal of immunology (Baltimore, Md : 1950) 2013;190:2495 -9. 22.